Protalix is a publicly traded biotechnology company (NYSE Amex: PLX), that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.


An innovative company striving for breakthroughs, Protalix represents biotechnology at its very best. We endeavor to find new and better remedies, combining cutting edge research and development. With our patients' quality of life in mind, we are working to offer better care and treatment. If you wish to be a part of our dynamic and challenging team, work in a young and friendly environment that allows you personal and professional growth, we're looking for you. Come join us and be part of the future.


© 2007 Protalix Biotherapeutics. All Rights Reserved.